new article annals internal medicine lays bare research commandeered marketing promotion vioxx merck former star painkiller personkiller article based chunk internal merck documents revealed legal proceedings unlike infamous zyprexa documents merck set study known advantage arthritis patients given vioxx arthritis patients took naproxen physicians across nation recruited enroll patients participate study intiated fda approval process vioxx study however conceived conducted merck marketing department vioxx come market merck needed develop need product hiring physicians participate investigators trial merck exposing product important group potential customers quote merck objectives provide product trial among key physician group accelerate uptake vioxx second entrant highly competitive new class gather data important customer group trial designed executed spirit merck marketing principles snippets merck marketing memo pithy commentary added free charge trial targeted select group critical customers main qualification research investigator trial customer merck wanted win sales force nominated potential investigators completed intake forms allowing large number sites evaluated enrolled ensuring equal distribution investigators across business groups sales force chose physicians apparently based easily could swayed prescribe vioxx result participating study analysis performed months post launch demonstrated significantly higher level prescribing vioxx among primary care advantage investigators compared control group vioxx prescribers see attached feedback field overwhelmingly positive ability access key customers influence involved trial perceptions vioxx merck program apparently desired results docs prescribing vioxx result participation merck marketing designed research patients dying due taking vioxx well little collateral damage quarterly sales goals met name exercise marketing seeding trial referring company planting seeds physicians use product guise research ii getting results according merck preparations underway analysis publication data utilize key investigators authors advisors turns worked pretty well lead author main advantage publication told new york times merck designed trial paid trial ran trial merck came me study completed said want help work paper initial paper written merck sent me editing sent place veneer academic credibility merck marketing run trial even merck head research said trials advantage intellectually redundant tend focus results already well established showing vioxx somewhat easier gastrointestinal tract naproxen harold sox drummond rennie also writing annals internal medicine critique vioxx marketing wrote practice seeding trial marketing guise science apparent purpose test hypothesis true purpose get physicians habit prescribing new drug would drug company go expense bother conducting trial involving hundreds practitioners recruiting patients study based large medical centers could accomplish scientific purposes much efficiently main point seeding trial get high quality scientific information change prescribing habits large numbers physicians secondary purpose transform physicians advocates sponsor drug company flatters physician selecting opinion leader incorporates research team title investigator pays good money consulting fee advise company drug use another fee patient enrolls physician becomes invested drug future praises good features patients colleagues unwittingly physician joins sponsor marketing team companies pursue expensive tactic works hardly biggest problem vioxx tendency kill people en masse via heart problems obviously far important issue know point merck made sure underplay risks vioxx medical community also asleep wheel came examining published studies risks vioxx nonetheless using guise science recruit naive greedy physicians serve vioxx pushers contemptible merck pushing wonderfully safe well tolerated via study designed solely turn investigators top vioxx prescribers time people meeting early end due purportedly safe new drug hot vioxx action check site update check interview dr kevin hill lead author investigation advantage trial carlat psychiatry blog always pharmalot also good post topic